← Open Payments lookup

GLORIA MAGUADOG: Open Payments

NPI 1316105232 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,638 in 224 payments from 19 companies in 2025. Trend: 2023 $4,085 · 2024 $5,018 · 2025 $4,638

Food & beverage: $4,417Education: $221
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.33$883
Teva Pharmaceuticals USA, Inc.35$745
Otsuka America Pharmaceutical, Inc.33$620
E.R. Squibb & Sons, L.L.C.27$480
Alkermes, Inc.23$464
Vanda Pharmaceuticals Inc.16$340
Janssen Pharmaceuticals, Inc18$299
Lundbeck LLC8$174
Supernus Pharmaceuticals, Inc.7$133
Tris Pharma Inc4$93

Products named: INGREZZA, REXULTI, COBENFY, ARISTADA, FANAPT, UZEDY, INVEGA SUSTENNA, AUSTEDO XR.

Industry payments across TX — which companies pay providers there.